Characteristics | Groups | Patients | X2 | p value | ||
---|---|---|---|---|---|---|
Total (N = 365) | Training cohort (N = 245) | Testing cohort (N =122) | ||||
Number | Number | Number | ||||
Sex | Male | 246 | 159 | 89 | 2.4096 | 0.2997 |
Female | 119 | 86 | 33 | |||
Age at diagnosis | Median | 61 | 61 | 61 | 0 | 1 |
Range | 16-90 | 16-85 | 20-90 | |||
Pathological TNM stage | I | 170 | 117 | 54 | 0.8923 | 0.9988 |
II | 84 | 55 | 30 | |||
III | 83 | 55 | 28 | |||
IV | 4 | 2 | 2 | |||
Unknown | 24 | 16 | 8 | |||
Histologic grade | G1 | 55 | 35 | 20 | 9.1377 | 0.3308 |
G2 | 175 | 112 | 64 | |||
G3 | 118 | 82 | 37 | |||
G4 | 12 | 12 | 0 | |||
Unknown | 5 | 4 | 0 | |||
Vital status | Alive | 234 | 154 | 82 | 0.6755 | 0.7134 |
Dead | 131 | 91 | 40 | |||
Adjacent hepatic tissue inflammation extent type | None | 117 | 75 | 43 | 2.774 | 0.8366 |
Mild | 98 | 63 | 36 | |||
Severe | 17 | 11 | 6 | |||
Unknown | 133 | 96 | 37 | |||
Person neoplasm cancer status | Tumor free | 161 | 110 | 52 | 0.1727 | 0.9965 |
With tumor | 122 | 81 | 42 | |||
Unknown | 82 | 54 | 28 | |||
Vascular tumor cell type | None | 205 | 144 | 62 | 3.1067 | 0.7953 |
Micro | 90 | 60 | 31 | |||
Macro | 16 | 9 | 7 | |||
Unknown | 54 | 32 | 22 | |||
Race | Asian | 155 | 106 | 50 | 2.6951 | 0.952 |
American Indian or Alaskan native | 1 | 1 | 0 | |||
Black or African American | 17 | 13 | 4 | |||
White | 182 | 120 | 63 | |||
Unknown | 10 | 5 | 5 | |||
Sample type | Primary tumor | 364 | 244 | 121 | 0.6672 | 0.7164 |
Recurrent tumor | 1 | 1 | 1 |